The American Diabetes Association's (ADA's) "Standards of Medical Care in Diabetes" is intended to provide cli-nicians, patients, researchers, payers, and other interested individuals with the components of diabetes care, gen-eral treatment goals, and tools to eval-uate the quality of care. The Standards of Care recommendations are not in-

The American Diabetes Association (ADA) has published its 2018 Clinical Standards of Medical Care guidelines focused on recommendations for the identification and management of cardiovascular (CV) risk factors in patients with diabetes.. A literature review of high-quality diabetes trials was performed by the ADA Professional Practice Committee, a group composed of physicians, diabetes Comparison of the diabetes guidelines from the ADA/EASD and the AACE/ACE Susan Cornell* article info Article history: Received 19 September 2016 Accepted 29 November 2016 abstract Objective: To compare recent diabetes guideline updates from the American Diabetes Asso-ciationeEuropean Association for the Study of Diabetes (ADA/EASD) and the 2016 ADA Standards of Medical Care in Diabetes—summary recommendations and companion slides are here. ADA Position Statement: Type 1 Diabetes Through the Lifespan - Released in 2014. Click here. ADA 2013 Nutrition Therapy Recommendations for the Management of Adults With Diabetes. Click here. PSAP 2013 ewharmrco/Ethrpwatrmrco 5 New Pharmacotherapies for Type 2 Diabetes Learning Objectives 1. Compare and contrast the differences between the drug therapy recommendations of several of the lat - est and leading diabetes guidelines. 2. Assess the differences in incretin-based therapies for the treatment of type 2 diabetes mellitus (T2DM) The documents below represent the official position of the American Association of Clinical Endocrinologists and American College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the particip